Clinical Trial

Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion

Name: Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion — clinical trial record (NCT07425171)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB in patients with long femoropopliteal lesions who underwent percutaneous transluminal angioplasty using GENOSS PCB.

Trial Details

NCT Number	NCT07425171
Lead Sponsor	Genoss Co., Ltd.
Conditions	PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease, Long Femoropopliteal Artery Disease
Enrollment	300 participants
Start Date	2026-02-24
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-20